National Health Investors’ (NHI) Buy Rating Reiterated at Stifel Nicolaus
National Health Investors, Inc. (NYSE:NHI)‘s stock had its “buy” rating reaffirmed by research analysts at Stifel Nicolaus in a research note issued to investors on Wednesday. They currently have a $82.00 target price on the real estate investment trust’s stock. Stifel Nicolaus’ price target indicates a potential upside of 5.28% from the stock’s current price.
A number of other analysts also recently weighed in on the company. BidaskClub upgraded National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, June 29th. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $89.00 price objective on the stock in a report on Wednesday, August 30th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $79.75.
National Health Investors (NYSE:NHI) opened at 77.89 on Wednesday. The stock’s 50 day moving average price is $79.16 and its 200 day moving average price is $76.54. The firm has a market capitalization of $3.19 billion, a P/E ratio of 20.00 and a beta of 0.56. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.21.
National Health Investors (NYSE:NHI) last released its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by ($0.36). The business had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 EPS. On average, equities analysts expect that National Health Investors will post $3.85 EPS for the current year.
TRADEMARK VIOLATION WARNING: “National Health Investors’ (NHI) Buy Rating Reiterated at Stifel Nicolaus” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/national-health-investors-nhi-buy-rating-reiterated-at-stifel-nicolaus/1606283.html.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 5.19% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after acquiring an additional 72,518 shares during the period. BlackRock Inc. increased its stake in National Health Investors by 6.6% in the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock valued at $280,927,000 after purchasing an additional 218,482 shares in the last quarter. Northern Trust Corp increased its stake in National Health Investors by 6.4% in the 2nd quarter. Northern Trust Corp now owns 1,007,869 shares of the real estate investment trust’s stock valued at $79,823,000 after purchasing an additional 60,784 shares in the last quarter. State Street Corp increased its stake in National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock valued at $79,133,000 after purchasing an additional 78,355 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in National Health Investors by 4.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 565,542 shares of the real estate investment trust’s stock valued at $44,790,000 after purchasing an additional 22,697 shares in the last quarter. 70.67% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.